基于机器学习的大型抑郁症生物标志物系统评估
该研究基于德国Marburg-Münster情感障碍队列研究(1801人,856例MDD,945例健康对照)及独立部分复制样本MNC(1198人),使用机器学习整合多种神经影像模态和多基因风险评分进行个体化诊断分类。
要点
- 整合多种神经影像模态及多基因风险评分未提升模型性能,按年龄、性别、治疗或缓解状态分层亦无改善。
- 模拟完美信度条件下性能未显著提高,模型误差分析提示症状严重度可能是识别MDD亚组的潜在方向。
核心结论
- 尽管多变量神经影像标志物较单变量标志物有更好的预测能力,但在大样本确诊患者中经广泛ML优化后仍未识别出有信息量的个体水平MDD生物标志物。
研究设计与样本
- 研究使用德国Marburg-Münster情感障碍队列研究数据,为病例对照临床神经影像研究,纳入18至65岁急性或终生MDD患者及健康对照,招募时间为2014年9月11日至2018年9月26日。
- Münster神经影像队列(MNC)作为独立部分复制样本,数据分析时间为2022年4月至2023年6月。
- 纳入分析的1801名参与者中,1162名(64.5%)为女性,平均(SD)年龄36.1(13.1)岁,包括856例MDD(47.5%)和945例健康对照(52.5%)。
- MNC复制样本包括1198人,其中362例MDD(30.1%)和836例健康对照(69.9%)。
主要发现
- 整合神经影像模态以及按年龄、性别、治疗或缓解状态分层均未提升模型性能。
- 研究结果在研究站点内得到复制,并在MNC的结构磁共振成像中观察到。
- 在模拟完美信度条件下,模型性能未显著改善。
- 分析模型误差提示症状严重度可能是识别MDD亚组的潜在重点。
临床怎么用
- 目前基于机器学习的多变量神经影像标志物尚不能用于MDD的个体化诊断分类。
- 临床实践中不应将此类ML模型作为MDD诊断生物标志物使用。
- 未来研究可关注症状严重度作为识别MDD亚组的潜在方向。
局限性
- 研究未发现可用的个体水平MDD生物标志物,但模型误差分析提示症状严重度可能是潜在方向,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Biological psychiatry aims to understand mental disorders in terms of altered neurobiological pathways. However, for one of the most prevalent and disabling mental disorders, major depressive disorder (MDD), no informative biomarkers have been identified. OBJECTIVE: To evaluate whether machine learning (ML) can identify a multivariate biomarker for MDD. DESIGN, SETTING, AND PARTICIPANTS: This study used data from the Marburg-Münster Affective Disorders Cohort Study, a case-control clinical neuroimaging study. Patients with acute or lifetime MDD and healthy controls aged 18 to 65 years were recruited from primary care and the general population in Münster and Marburg, Germany, from September 11, 2014, to September 26, 2018. The Münster Neuroimaging Cohort (MNC) was used as an independent partial replication sample. Data were analyzed from April 2022 to June 2023. EXPOSURE: Patients with MDD and healthy controls. MAIN OUTCOME AND MEASURE: Diagnostic classification accuracy was quantified on an individual level using an extensive ML-based multivariate approach across a comprehensive range of neuroimaging modalities, including structural and functional magnetic resonance imaging and diffusion tensor imaging as well as a polygenic risk score for depression. RESULTS: Of 1801 included participants, 1162 (64.5%) were female, and the mean (SD) age was 36.1 (13.1) years. There were a total of 856 patients with MDD (47.5%) and 945 healthy controls (52.5%). The MNC replication sample included 1198 individuals (362 with MDD [30.1%] and 836 healthy controls [69.9%]). Training and testing a total of 4 million ML models, mean (SD) accuracies for diagnostic classification ranged between 48.1% (3.6%) and 62.0% (4.8%). Integrating neuroimaging modalities and stratifying individuals based on age, sex, treatment, or remission status does not enhance model performance. Findings were replicated within study sites and also observed in structural magnetic resonance imaging within MNC. Under simulated conditions of perfect reliability, performance did not significantly improve. Analyzing model errors suggests that symptom severity could be a potential focus for identifying MDD subgroups. CONCLUSION AND RELEVANCE: Despite the improved predictive capability of multivariate compared with univariate neuroimaging markers, no informative individual-level MDD biomarker-even under extensive ML optimization in a large sample of diagnosed patients-could be identified.
引用
- Winter NR, Blanke J, Leenings R, et al. A Systematic Evaluation of Machine Learning-Based Biomarkers for Major Depressive Disorder. JAMA Psychiatry. 2024. PMID: 38198165. doi:10.1001/jamapsychiatry.2023.5083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。